Guo Jing-jin, Liang Wei-xiong, Zhang Tong
Department of General Surgery, Panyu Center Hospital of Guangzhou, Guangzhou 511400, China.
Zhonghua Wei Chang Wai Ke Za Zhi. 2010 Aug;13(8):598-600.
To evaluate outcomes after different treatment options including endoscopic stent placement, surgical bypass, and percutaneous gastrostomy for malignant gastric outlet obstruction (GOO).
Thirty-nine patients with GOO secondary to unresectable primary or metastatic cancer were treated with endoscopic stent placement (group 1, n=13), surgical bypass (group 2, n=21), or percutaneous gastrostomy (group 3, n=5). QLQ-STO22 form was used to assess quality of life (QOL) at baseline, 1 month, and 3 months following intervention.
Overall median survival time was 68 days. Median survival time in group 1 and group 2 was 85 and 72 days respectively, longer than that in group 3 (48 days, P<0.05). Fourteen patients (7 cases in group 1 and 7 cases in group 2) completed all three QOL surveys. All the patients in group 1 had significant improvement in dysphagia, dietary restrictions, dry mouth, and reflux (P<0.05). In group 2, dysphagia and dietary restrictions were significantly improved (P<0.05), while there were no significant improvements in dry mouth, reflux and pain (all P>0.05).
Although the prognosis of malignant GOO is poor, endoscopic stent placement and surgical bypass may improve QOL of patients and therefore are reasonable alternatives for palliation.
评估包括内镜支架置入、手术旁路和经皮胃造瘘术在内的不同治疗方案对恶性胃出口梗阻(GOO)的治疗效果。
39例因不可切除的原发性或转移性癌症继发GOO的患者接受了内镜支架置入(第1组,n = 13)、手术旁路(第2组,n = 21)或经皮胃造瘘术(第3组,n = 5)治疗。采用QLQ - STO22量表在干预前、干预后1个月和3个月评估生活质量(QOL)。
总体中位生存时间为68天。第1组和第2组的中位生存时间分别为85天和72天,长于第3组(48天,P<0.05)。14例患者(第1组7例,第2组7例)完成了所有三项QOL调查。第1组所有患者在吞咽困难、饮食限制、口干和反流方面均有显著改善(P<0.05)。第2组患者的吞咽困难和饮食限制有显著改善(P<0.05),而口干、反流和疼痛方面无显著改善(均P>0.05)。
尽管恶性GOO的预后较差,但内镜支架置入和手术旁路可改善患者的生活质量,因此是合理的姑息治疗选择。